BioAffinity Technologies Inc (NASDAQ:BIAF) shares, rose in value on Wednesday, June 18, with the stock price down by -6.55% to the previous day’s close as strong demand from buyers drove the stock to $0.25.
Actively observing the price movement in the last trading, the stock closed the session at $0.27, falling within a range of $0.245 and $0.268. The value of beta (5-year monthly) was 2.557. Referring to stock’s 52-week performance, its high was $2.99, and the low was $0.16. On the whole, BIAF has fluctuated by 11.58% over the past month.
With the market capitalization of BioAffinity Technologies Inc currently standing at about $7.15 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-15.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 6.5M, with a low estimate of 1.51M and a high estimate of 1.51M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 1.51M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that BIAF’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of BIAF currently trading nearly -12.88% and -28.93% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 42.27, while the 7-day volatility ratio is showing 5.34% which for the 30-day chart, stands at 11.62%. Furthermore, BioAffinity Technologies Inc (BIAF)’s beta value is 2.56, and its average true range (ATR) is 0.05.
A comparison of BioAffinity Technologies Inc (BIAF) with its peers suggests the former has fared considerably weaker in the market. BIAF showed an intraday change of -6.55% in last session, and over the past year, it shrunk by -87.44%%.
Data on historical trading for BioAffinity Technologies Inc (NASDAQ:BIAF) indicates that the trading volumes over the past 10 days have averaged 1.66 and over the past 3 months, they’ve averaged 12.25 million. According to company’s latest data on outstanding shares, there are 28.46 million shares outstanding.
Nearly 28.84% of BioAffinity Technologies Inc’s shares belong to company insiders and institutional investors own 1.80% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 1.61 million shares as on 2025-05-30, resulting in a short ratio of 0.19. According to the data, the short interest in BioAffinity Technologies Inc (BIAF) stood at 643.00 of shares outstanding as of 2025-05-30; the number of short shares registered in 2025-04-30 reached 0.29 million. The stock has fallen by -72.41% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BIAF stock heading into the next quarter.
